Categories: Automobile

Nissan Selects IPfolio from Clarivate

Managing IP with advanced workflow automation technology and leading data

- Advertisement -

LONDON, Dec. 18, 2025 /PRNewswire/ — Clarivate Plc (NYSE: CLVT), a leading global provider of transformative intelligence, announced today that Nissan Motor Co., Ltd (Nissan: 7201.T) has selected IPfolio. This intellectual property management software (IPMS) will help Nissan manage and protect its IP more efficiently with advanced workflow automation technology and world-leading data and analytics.

- Advertisement -

With the implementation of IPfolio, Nissan will establish an IPMS that is scalable for the future by developing workflows customized for operations, enhancing data visibility, and enabling integration with other data sources through an Application Programming Interface (API).

- Advertisement -

David Curren, Deputy General Manager of Intellectual Property Department, Nissan Motor Co., Ltd., said: “To address the increasing importance of intellectual property in the automotive industry, Nissan has selected IPfolio from Clarivate to help modernize and streamline its IP operations. The implementation will enable the Nissan IP team to manage its portfolio with greater control, efficiency, and strategic foresight. We are confident that IPfolio will be a key enabler in our mission to protect our intellectual property and strengthen our competitive position.”

- Advertisement -

Maroun S. Mourad, President, Intellectual Property, Clarivate, said: “We are very pleased to support Nissan in transforming the way they manage and protect IP. Blending advanced technologies with decades of IP expertise, our trusted solutions will empower them to elevate IP management, accelerate innovation and mitigate business risk.”

- Advertisement -

About Clarivate 
Clarivate is a leading global provider of transformative intelligence. We offer enriched data, insights & analytics, workflow solutions and expert services in the areas of Academia & Government, Intellectual Property and Life Sciences & Healthcare. For more information, please visit www.clarivate.com

- Advertisement -

Media Contact:
Jack Wan, Director, External Communications
newsroom@clarivate.com

- Advertisement -

Logo – https://mma.prnewswire.com/media/1159266/Clarivate_Logo_v1.jpg

- Advertisement -

View original content:https://www.prnewswire.co.uk/news-releases/nissan-selects-ipfolio-from-clarivate-302643654.html

- Advertisement -
PRNW Agency

Recent Posts

Novartis Vanrafia Phase III data support slowing of kidney function decline in patients with IgA nephropathy

Basel, February 13, 2026 – Novartis today announced final results from the Phase III ALIGN…

4 days ago

January Commercial Chapter 11 Filings Increase 76% Over 2025

NEW YORK, Feb. 06, 2026 (GLOBE NEWSWIRE) -- There were 956 commercial Chapter 11 filings…

1 week ago

Novartis breaks ground on new global Biomedical Research center in San Diego to accelerate drug discovery

Basel, February 6, 2026 – Novartis today broke ground on a new, state-of-the-art global Biomedical…

2 weeks ago

Novartis ianalumab receives FDA Breakthrough Therapy designation for Sjgrens disease

Basel, January 16, 2026 – Novartis today announced that the US Food and Drug Administration (FDA)…

1 month ago

Personar Appoints Former Genius Sports COO Eric Stevens as Chief Operating Officer to Scale Award-Winning Sports Technology Platform

Tuesday 13 January, 2026 LONDON – Tuesday, January 13, 2026 – Personar, the AI sports…

1 month ago

Novartis to add radioligand therapy manufacturing facility in Winter Park, Florida, fourth in US to serve patients and advance $23 billion investment

Basel, January 9, 2026 – Novartis, a leading global innovative medicines company, today announced plans…

1 month ago